Skip to main content
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
127.74
+0.62 (0.49%)
At close: Nov 12, 2024, 4:00 PM
128.51
+0.77 (0.60%)
Pre-market: Nov 13, 2024, 6:43 AM EST

Jazz Pharmaceuticals Revenue

Jazz Pharmaceuticals had revenue of $1.05B in the quarter ending September 30, 2024, with 8.52% growth. This brings the company's revenue in the last twelve months to $3.99B, up 5.23% year-over-year. In the year 2023, Jazz Pharmaceuticals had annual revenue of $3.83B with 4.78% growth.

Revenue (ttm)
$3.99B
Revenue Growth
+5.23%
P/S Ratio
1.99
Revenue / Employee
$1,425,969
Employees
2,800
Market Cap
7.72B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.83B174.83M4.78%
Dec 31, 20223.66B565.14M18.26%
Dec 31, 20213.09B730.67M30.91%
Dec 31, 20202.36B201.81M9.34%
Dec 31, 20192.16B270.84M14.32%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.81B
Bausch + Lomb 4.68B
Elanco Animal Health 4.45B
Halozyme Therapeutics 947.36M
Legend Biotech 455.99M
Glaukos 360.35M
Ascendis Pharma 340.33M
Cytokinetics 3.22M
Revenue Rankings

JAZZ News

More News